PLURISTEM THERAPEUTICS INC - FORM 10-K - EX-23.1 - CONSENT OF KOST FORER GABBAY & KASIERER, A MEMBER OF ERNST & YOUNG GLOBAL - September 13, 2021

Attached files

file filename
EX-32.2 - CERTIFICATION - PLURISTEM THERAPEUTICS INCf10k2021ex32-2_pluristem.htm
EX-32.1 - CERTIFICATION - PLURISTEM THERAPEUTICS INCf10k2021ex32-1_pluristem.htm
EX-31.2 - CERTIFICATION - PLURISTEM THERAPEUTICS INCf10k2021ex31-2_pluristem.htm
EX-31.1 - CERTIFICATION - PLURISTEM THERAPEUTICS INCf10k2021ex31-1_pluristem.htm
EX-23.2 - CONSENT OF KESSELMAN & KESSELMAN, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - PLURISTEM THERAPEUTICS INCf10k2021ex23-2_pluristem.htm
EX-10.30 - LETTER AGREEMENT BY AND BETWEEN PLURISTEM LTD. AND CHEN FRANCO-YEHUDA, DATED SEP - PLURISTEM THERAPEUTICS INCf10k2021ex10-30_pluristem.htm
EX-10.29 - LETTER AGREEMENT BY AND BETWEEN PLURISTEM LTD. AND YAKY YANAY, DATED SEPTEMBER 1 - PLURISTEM THERAPEUTICS INCf10k2021ex10-29_pluristem.htm
EX-10.28 - LETTER AGREEMENT BY AND BETWEEN PLURISTEM LTD. AND ROSE HIGH TECH LTD., DATED SE - PLURISTEM THERAPEUTICS INCf10k2021ex10-28_pluristem.htm
EX-10.20 - FORM OF RESTRICTED STOCK UNIT AGREEMENT (EMPLOYEES) UNDER THE 2019 EQUITY COMPEN - PLURISTEM THERAPEUTICS INCf10k2021ex10-20_pluristem.htm
EX-10.19 - FORM OF RESTRICTED SHARE UNIT AGREEMENT (ISRAELI DIRECTORS AND OFFICERS) UNDER T - PLURISTEM THERAPEUTICS INCf10k2021ex10-19_pluristem.htm
EX-10.18 - FORM OF RESTRICTED SHARE UNIT AGREEMENT UNDER THE 2019 EQUITY COMPENSATION PLAN - PLURISTEM THERAPEUTICS INCf10k2021ex10-18_pluristem.htm
10-K - ANNUAL REPORT - PLURISTEM THERAPEUTICS INCf10k2021_pluristemtherap.htm

Exhibit 23.1

 

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in the Registration Statement on Form S-3 (Registration No. 333-239890) and in the Registration Statement on Form S-8 (Registration No. 333- 248685, 333-248686, , 333-229535, 333-222888, 333-217770, 333-212299, 333-206848, 333-196537, 333-173777 and 333-162577) pertaining to the Amended and Restated 2005 Stock Option Plan, the 2016 Equity Compensation Plan and the 2019 Equity Compensation Plan of Pluristem Therapeutics Inc. of our report dated September 10, 2020, with respect to the consolidated financial statements of Pluristem Therapeutics Inc., included in this Annual Report (Form 10-K) of Pluristem Therapeutics Inc., dated September 13, 2021.

 

Tel Aviv, Israel   /s/ Kost Forer Gabbay & Kasierer
September 13, 2021   A Member of Ernst & Young Global

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

A member firm of Ernst & Young Global Limited

PLURISTEM THERAPEUTICS INC Reports